Synthesis of novel 7α-thiol-bridged progesterone derivatives

Synthetic Communications

Volumn 33, Issue 6, 2003, Pages 885-893

  Wynne, James H ^a   Lloyd, Christopher T ^a   Mushrush, George W ^a  

^a NAVAL RESEARCH LABORATORY   (United States)

Author keywords

Breast cancer; Enantioselective synthesis; Progesterone; Steroids

Indexed keywords

1 [4 [7ALPHA (PREGNA 4 EN 3,20 DIONE)]SULFANYLPHENYL] 3 (1ALPHA PHENYLETHYL)UREA; 1 [4 [7ALPHA (PREGNA 4 EN 3,20 DIONE)]SULFANYLPHENYL] 3 (2 CHLOROETHYL)UREA; 1 [4 [7ALPHA (PREGNA 4 EN 3,20 DIONE)]SULFANYLPHENYL] 3 (4 TOLUENESULFONYL)UREA; 1 [4 [7ALPHA (PREGNA 4 EN 3,20 DIONE)]SULFANYLPHENYL] 3 ETHYLUREA; 7ALPHA [4 (AMINOPHENYL)THIO]PREGNA 4 EN 3,20 DIONE; 7ALPHA BENZYLPREGNA 4 EN 3,20 DIONE; ISOCYANIC ACID DERIVATIVE; KETONE; PHENOL DERIVATIVE; PREGNA 4,6 DIEN 3,20 DIONE 20 ETHYLENE KETAL; PROGESTERONE DERIVATIVE; STEROID; THIOL DERIVATIVE; UNCLASSIFIED DRUG;

ADDITION REACTION; ARTICLE; BREAST CANCER; CONJUGATE; DRUG SYNTHESIS; ENANTIOSELECTIVITY; HYDROGENATION;

EID: 0037263011     PISSN: 00397911     EISSN: None     Source Type: Journal    
DOI: 10.1081/SCC-120016346     Document Type: Article

References (20)

1. Miller, A.B.; Bulbrook, R.D. UICC Multidisciplinary Project on Breast-Cancer. The Epidemiology, Etiology and Prevention of Breast-Cancer. Int. J. Cancer 1986, 37 (2), 173-177.
2. Park, T.K.; Kim, I.J.; Hu, S.; Bilodeau, M.T.; Randolph, J.T.; Kwon, O.; Danishefsky, S.J. Total synthesis and proof of structure of a human breast tumor (Globo-H) antigen. J. Am. Chem. Soc. 1996, 118 (46), 11488-11500.
3. Henderson, I.C.; Shapiro, C.L. Adjuvant chemotherapy: an overview. In Medicinal Management of Breast Cancer, Powels, T., Smith, I.E., Eds.; Dunitz: London, 1991; 197-215.
4. Clarke, R.; Leonessa, F. Cytotoxic drugs and hormones in breast cancer: interactions at the cellular level. In Drug and Hormonal Resistance in Breast Cancer: Cellular and Molecular Mechanisms, Dickson, R.B., Lippman, M.E., Eds.; Ellis Horwood: Chichester, UK, 1994, 407-432.
5. Clarke, R.; Thompson, E.W.; Leonessa, F.; Lippman, J.; McGarvey, M.; Brunner, N. Hormone resistance, invasiveness, and metastatic potential in breast-cancer. Breast Cancer Res. Treat. 1993, 24 (3), 227-239.
6. 13C in the Steroid A Ring. Part 1. Tetrahedron 2000, 56, 9957-9965;
7. 13C in the Steroid A Ring. Part 2. Tetrahedron 2000, 56, 9967-9974;
8. (c) Tomida, S.; Doi, T.; Takahashi, T. New Approach to the Progesterone BCD-Ring System by Utilizing a Tandem Transannular Radical Cyclization. Tetrahedron Lett. 1999, 40, 2363-2366.
9. (a) Skaddan, M.B.; Wüst, F.R.; Katzenellenbogen, J. A. Synthesis and Binding Affinities of Novel Re-Containing 7α-Substituted Estradiol Complexes: Models for Breast Cancer Imaging Agents. J. Org. Chem. 1999, 64 (22), 8108-8121; (b) Darby, M.V.; Baker, D.; Moh, P.P.; Brueggemeier, R.W. Radioiodinated Steroidal Aromatase Inhibitors for Mechanistic and Metabolic Studies. The Quarterly Journal of Nuclear Medicine 1995, 54-55; (c) Lovely, C.J.; Brueggemeier, R.W. Synthesis of 7-Alpha-Substituted Androstenediones by a 1,4-conjugate addition approach. Bioorganic and Medicinal Chemistry Letters 1995, 5 (21), 2513-2516; (d) Brueggemeier, R.W. Aromatase Inhibitors-Mechanism of Steroidal Inhibitors. Breast Cancer Research and Treatment 1994, 30 (1), 31-42; (e) O'Reilly, J.M.; Brueggemeier, R.W. Development of Steroidal and Nonsteroidal Inhibitors of Aromatase for the Treatment of Hormone-Dependent Breast Cancer. Current Medicinal Chemistry 1996, 3 (1), 11-22.
10. (a) Skaddan, M.B.; Wüst, F.R.; Katzenellenbogen, J. A. Synthesis and Binding Affinities of Novel Re-Containing 7α-Substituted Estradiol Complexes: Models for Breast Cancer Imaging Agents. J. Org. Chem. 1999, 64 (22), 8108-8121; (b) Darby, M.V.; Baker, D.; Moh, P.P.; Brueggemeier, R.W. Radioiodinated Steroidal Aromatase Inhibitors for Mechanistic and Metabolic Studies. The Quarterly Journal of Nuclear Medicine 1995, 54-55; (c) Lovely, C.J.; Brueggemeier, R.W. Synthesis of 7-Alpha-Substituted Androstenediones by a 1,4-conjugate addition approach. Bioorganic and Medicinal Chemistry Letters 1995, 5 (21), 2513-2516; (d) Brueggemeier, R.W. Aromatase Inhibitors-Mechanism of Steroidal Inhibitors. Breast Cancer Research and Treatment 1994, 30 (1), 31-42; (e) O'Reilly, J.M.; Brueggemeier, R.W. Development of Steroidal and Nonsteroidal Inhibitors of Aromatase for the Treatment of Hormone-Dependent Breast Cancer. Current Medicinal Chemistry 1996, 3 (1), 11-22.
11. (a) Skaddan, M.B.; Wüst, F.R.; Katzenellenbogen, J. A. Synthesis and Binding Affinities of Novel Re-Containing 7α-Substituted Estradiol Complexes: Models for Breast Cancer Imaging Agents. J. Org. Chem. 1999, 64 (22), 8108-8121; (b) Darby, M.V.; Baker, D.; Moh, P.P.; Brueggemeier, R.W. Radioiodinated Steroidal Aromatase Inhibitors for Mechanistic and Metabolic Studies. The Quarterly Journal of Nuclear Medicine 1995, 54-55; (c) Lovely, C.J.; Brueggemeier, R.W. Synthesis of 7-Alpha-Substituted Androstenediones by a 1,4-conjugate addition approach. Bioorganic and Medicinal Chemistry Letters 1995, 5 (21), 2513-2516; (d) Brueggemeier, R.W. Aromatase Inhibitors-Mechanism of Steroidal Inhibitors. Breast Cancer Research and Treatment 1994, 30 (1), 31-42; (e) O'Reilly, J.M.; Brueggemeier, R.W. Development of Steroidal and Nonsteroidal Inhibitors of Aromatase for the Treatment of Hormone-Dependent Breast Cancer. Current Medicinal Chemistry 1996, 3 (1), 11-22.
12. (a) Skaddan, M.B.; Wüst, F.R.; Katzenellenbogen, J. A. Synthesis and Binding Affinities of Novel Re-Containing 7α-Substituted Estradiol Complexes: Models for Breast Cancer Imaging Agents. J. Org. Chem. 1999, 64 (22), 8108-8121; (b) Darby, M.V.; Baker, D.; Moh, P.P.; Brueggemeier, R.W. Radioiodinated Steroidal Aromatase Inhibitors for Mechanistic and Metabolic Studies. The Quarterly Journal of Nuclear Medicine 1995, 54-55; (c) Lovely, C.J.; Brueggemeier, R.W. Synthesis of 7-Alpha-Substituted Androstenediones by a 1,4-conjugate addition approach. Bioorganic and Medicinal Chemistry Letters 1995, 5 (21), 2513-2516; (d) Brueggemeier, R.W. Aromatase Inhibitors-Mechanism of Steroidal Inhibitors. Breast Cancer Research and Treatment 1994, 30 (1), 31-42; (e) O'Reilly, J.M.; Brueggemeier, R.W. Development of Steroidal and Nonsteroidal Inhibitors of Aromatase for the Treatment of Hormone-Dependent Breast Cancer. Current Medicinal Chemistry 1996, 3 (1), 11-22.
13. (a) Skaddan, M.B.; Wüst, F.R.; Katzenellenbogen, J. A. Synthesis and Binding Affinities of Novel Re-Containing 7α-Substituted Estradiol Complexes: Models for Breast Cancer Imaging Agents. J. Org. Chem. 1999, 64 (22), 8108-8121; (b) Darby, M.V.; Baker, D.; Moh, P.P.; Brueggemeier, R.W. Radioiodinated Steroidal Aromatase Inhibitors for Mechanistic and Metabolic Studies. The Quarterly Journal of Nuclear Medicine 1995, 54-55; (c) Lovely, C.J.; Brueggemeier, R.W. Synthesis of 7-Alpha-Substituted Androstenediones by a 1,4-conjugate addition approach. Bioorganic and Medicinal Chemistry Letters 1995, 5 (21), 2513-2516; (d) Brueggemeier, R.W. Aromatase Inhibitors-Mechanism of Steroidal Inhibitors. Breast Cancer Research and Treatment 1994, 30 (1), 31-42; (e) O'Reilly, J.M.; Brueggemeier, R.W. Development of Steroidal and Nonsteroidal Inhibitors of Aromatase for the Treatment of Hormone-Dependent Breast Cancer. Current Medicinal Chemistry 1996, 3 (1), 11-22.
14. Iyer, V.V.; Griesgraber, G.W.; Radmer, M.R.; McIntee, E.J.; Wagner, C.R. Synthesis, in Vitro Anti-Breast Cancer Activity, and Intracellular Decomposition of Amino Acid Methyl Ester and Alkyl Amide Phosphoramidate Monoesters of 3′-Azido-3′-deoxythymidine (AZT). J. Med. Chem. 2000, 43 (11), 2266-2274.
15. Fieser, L.F.; Fieser, M. Steroids; Reinhold: New York, 1959.
16. Davis, B.R.; Johnson, S.J. Diterpene Synthesis. Part 1. Copper-catalysed 1,6-addition of a benzyl grignard reagent to a dieone. J. Chem. Soc. Perk. Trans I 1979, 2840-2844.
17. Gut, M. 3β-Hydroxypregn-4-en-20-one. J. Org. Chem. 1956, 21 (11), 1327-1328.
18. Turner, A.B.; Ringold, H.J. Applications of High-potential Quinones. Part 1. The Mechanism of Dehydrogenation of Steroidal ketones by 2,3-Dichloro-5,6-dicyanobenzoquinone. J. Chem. Soc. 1967, 1720-1730.
19. Highet, R.J.; Burke, T.R.; Trager, W.F.; Pohl, L.R.; Menard, R.H.; Taburet, A.M.; Gillette, J.R. C-13 nuclear magnetic-resonance studies of spironolactone and several related steroids. Steroids 1980, 35 (2), 119-132.
20. Brueggemeier, R.W.; Floyd, E.E.; Counsell, R.E. Synthesis and Biochemical Evaluation of inhibitors of estrogen biosynthesis. J. Med. Chem. 1978, 21, 1007-1011.